top of page

EMA accepts submission for Zebinix use as a monotherapy for partial-onset seizures

The European Medicines Agency (EMA) has accepted Bial’s submission for once-daily epilepsy treatment Zebinix as monotherapy for partial-onset seizures.

Click on this link for more information.

source: http://www.europeanpharmaceuticalreview.com/41144/news/industry-news/ema-zebinix-monotherapy-partial-onset-seizures/

#Pharmanews

Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page